The global healthcare industry is witnessing unprecedented innovation in addressing hyperparathyroidism, a metabolic disorder that disrupts calcium regulation and bone health. This endocrine condition, affecting parathyroid gland function and hormone production, has emerged as a significant therapeutic target with expanding market potential. The comprehensive Hyperparathyroidism Treatment Market analysis reveals promising developments in both pharmaceutical interventions Read.